RIO DE JANEIRO, Sept 3 (Reuters) - Brazil has rejected a patent request for an AIDS drug made by U.S. firm Gilead, opening the way for cheaper, generic versions to be used in the country’s fight against the disease.
RIO DE JANEIRO, Sept 3 (Reuters) - Brazil has rejected a patent request for an AIDS drug made by U.S. firm Gilead, opening the way for cheaper, generic versions to be used in the country’s fight against the disease.
